3D-Bioprinting "Track B"

Date: Thursday, 4 October 2018 - Friday, 5 October 2018
Location: Coronado Island, California

Keynote Speakers

Dong-Woo Cho
Professor, Pohang University of Science and Technology (POSTECH)

Reyk Horland
CEO, TissUse GmbH

Michael Gelinsky
Professor and Head, Center for Translational Bone, Joint and Soft Tissue Research, Faculty of Medicine, Technische Universität Dresden

Nancy Allbritton
Kenan Professor of Chemistry and Biomedical Engineering and Chair of the Joint Department of Biomedical Engineering, University of North Carolina and North Carolina State University

Paul Gatenholm
Professor, Director of 3D Bioprinting Center, Chalmers University of Technology, Sweden; CEO, CELLHEAL AS, Norway

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Shoji Takeuchi
Professor, Center For International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science, The University of Tokyo

Shaochen Chen
Professor and Chair, NanoEngineering Department, University of California-San Diego

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Linda Griffith
Professor, Massachusetts Institute of Technology (MIT)

Overview

Welcome to the 3D-Bioprinting Conference Track Co-Located and Running Concurrently with the Following Conferences:

Organ-on-a-Chip World Congress 2018
Stem Cells in Drug Discovery, Tox Screening and 3D-Culture 2018
3D-Culture and Organoids 2018

Currently the field of 3D-bioprinting is exploding. The goals of realizing the full potential of regenerative medicine through 3D-bioprinting technology and tissue engineering are slowly being realized. This conference will bring together many of the major academic players in this arena as well as important industry stakeholders in the relevant ever-expanding fields.

The conference will address the challenges, technology and regulation issues pertaining to 3D printing in science. With a well-known track record for delivering high quality agendas, this event will include talks from some of the world’s foremost leaders in bioprinting, tissue regeneration, microfluidics and toxicology. There will be sessions focused on cell sourcing, bioprinting, biomaterials, scaffolding, immunology and toxicology.

Posters from delegates are welcomed as a means to disseminate the most up-to-date research and commercial applications which complement the presentations from the leaders in these fields.

Information and Local Registration Facilities for this Conference are also available in:

Japanese | Korean | Chinese (Simplified) | Chinese (Traditional)

Agenda Topics

3D Bioprinting of Multilevel Vessels
Light-based Additive Manufacturing for Tissue Engineering
Material Considerations for 3D Printing in Tissue Engineering
Organ Printing
Remote (Light, Magnetic, Ultrasound) Guided Delivery of Cells and Site and Time Specific Activation of Biologically Active Compounds
Stem Cell Bioprinting using a Hybrid Microporous Bioink
The Importance of Cell Phenotype in 3D Printing

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Luiz Bertassoni, Associate Professor, Biomaterials and Biomechanics, School of Dentistry, Cancer Early Detection Advanced Research, Knight Cancer Institute, Oregon Health & Sciences University
John Hundley Slater, Associate Professor of Biomedical Engineering, University of Delaware
Joseph Kinsella, Assistant Professor of Bioengineering, McGill University
Hector Martínez, Chief Technology Officer, CELLINK
Taciana Pereira, Director of Bioengineering, Allevi, Inc.
Robert Ramirez, Chief Scientist, FUJIFILM Dimatix
William G Whitford, Life Science Strategic Solutions Leader, DPS Group
Y. Shrike Zhang, Associate Bioengineer, Division of Engineering in Medicine, Harvard-MIT Division of Health Sciences and Technology